Pomanox™ honored as Finalist for NutraIngredients’ Awards

Naturopathic News

Euromed’s most recent entry in Botanical Extracts – Pomanox — is honored as a Finalist for NutraIngredients’ Awards “Ingredient of the Year for the Healthy Ageing” Category

Bridgeville, PA                                                                                                                            March 29th, 2018
Once again, Euromed – a long time industry leader in creating traditional and innovative botanical extracts – has been acknowledged as such. Their latest ingredient, Pomanox™, an extract from Pomegranate whole fresh fruit, has been given the honor of being one of only three (3) ingredients up for the prestigious award as Ingredient of the Year for Healthy Ageing. It was just late last year that Euromed announced their acquisition of Probelte Biotechnology, a premium manufacturer of nutraceutical ingredients, and the originator of this unique pomegranate ingredient.

ABOUT POMANOX
It is a significant honor for Euromed to have one of their premium botanical extracts be one of only three ingredients included in the all-encompassing Healthy Ageing Category.  The reasons for that is the abundance of scientific evidence about this potent, pure extract of the Pomegranate fruit that Euromed manufactures through an innovative and patented water only extraction technology. Pomanox is the result of more than 7 years of research and development by Probelte Bio, a Spanish company that was recently added to the Euromed platform. This new production plant further expands Euromed’s capabilities with very modern state of the art facilities and the added value of a water-based extraction and eco-friendly technologies and extracts.

PomanoxTM is a pomegranate extract standardized to up 30% of the potent polyphenols Punicalagins from a fully integrated supply chain controlling each step of this pomegranate’s cultivation, harvesting and collection. The hallmarks of Euromed’s commitments are: Vertical integration, Quality Control and full traceability.

In vitro, pre-clinical and clinical studies indicate that PomanoxTM can support key functions of the cardiovascular system, notably endothelial functions, while providing additional health benefits relevant to healthy ageing, such as modulation of inflammatory and metabolic responses, reduction of blood pressure, anti-oxidant, and anti-fatigue effects. Additionally, proprietary data suggests beneficial effects on the intestinal flora, among others. Further studies are planned.

Guy Woodman, General Manager of Euromed USA, enthused “The extensive research conducted by our Probelte divison prides itself on conducting scientific studies to verify the health benefits of utilizing its botanical products. We’re  delighted that this 7-year investment in efficacy studies on Pomanox™, a special patented whole fruit pomegranate extract, was recognized by the industry and is one of this year’s nominees for  the prestigious NutraIngredient Awards.”

ABOUT NUTRAINGREDIENTS
The winners of this prestigious Award will be announced during the upcoming Vitafoods Europe show to be held in Geneva, Switzerland on May 15th to 17th, 2018.  Rewarding true innovation, long term market success, and cutting edge research in healthy foods, supplements and functional nutrition, the 2018  Wednesday night NutraIngredients Award gala will host an industry-wide celebration of success.

Their expert judging panel has trimmed down the huge number of entries to create a shortlist of finalists that will now go forward for the second round of judging, to take place in Geneva immediately before the winners are announced on day two of the show. It is considered to be a festival of celebration for the nutraceutical and nutritional ingredients world, with large and small scale companies included in the 33-strong shortlist of finalists in ten (10) categories.

Read the full article here:  https://www.nutraingredients.com/Article/2018/03/22/Who-made-the-final-NutraIngredients-Awards-shortlist-announced#

ABOUT EUROMED
Euromed supplies standardized botanical and herbal extracts and natural active substances for use in the dietary supplement, pharmaceutical, and cosmetics industries. By standardizing the whole journey, from seed to consumer, the company can guarantee  a standardized, precise and consistent level of the beneficial phytochemicals nature has provided, and that each batch of its extracts meets the same profile documented in clinical studies to be safe and effective. Euromed was founded 48 years ago; the company was recently acquired by The Riverside Company, with its US offices located in Bridgeville, Pennsylvania.  For additional information about Euromed’s extracts, call 877-696-3960 or email BeSure@EuromedUSA.com and visit www.EuromedUSA.com

Advertisement

Current Issue

Table of Contents

Advertisement

Trending Articles

Restorative Formulations Launches the NeuroSynergy Clinical Series

Restorative Formulations Launches the NeuroSynergy Clinical Series

Four professional-grade formulas targeting distinct neurochemical pathways to support  mood, stress resilience, and cognitive function are now available exclusively to licensed  practitioners.  Montpelier, VT, March 27, 2026 — Restorative Formulations has released the...

Allergy Research News Release

Allergy Research News Release

RAZI BERRY Allergy Research Group Announces Peer-Reviewed Publication Advancing Thyroid and Endocrine Integration Science Collaborative research led by ARG’s Medical Affairs and Scientific Advisory Board reinforces the company’s commitment to thyroid category...

Three Endocrine Axes Share One Energy Budget for Stress Resilience

Three Endocrine Axes Share One Energy Budget for Stress Resilience

Three Endocrine Axes Share One Energy Budget for Stress Resilience Mitochondrial reserve capacity constrains the HPA, thyroid, and gonadal systems simultaneously, determining whether stress responses stay adaptive or consolidate into chronic dysfunction. When a...

Custom Publishing

Quantum Energy Effects on Cell Recovery Rates

Quantum Energy Effects on Cell Recovery Rates

Author: Robert Sheaff, PhD, and Ian Mitchell Abstract This study investigated whether quantum field exposure generated by Leela Quantum Bloc Technology influences cell recovery rates in human cell lines. A series of double-blind experiments were conducted using Human...

Quantum Fields and Frequency Medicine

RAZI BERRY Quantum Fields and Frequency Medicine A Conversation with Philipp Samor von Holtzendorff Fehling on Remote Quantum Technology and Human Performance Interest in frequency medicine and subtle energy technologies continues to grow...

Featured News